Medicine
Feraheme 510 mg/17 mL injection
Feraheme 510 mg/17 mL injection is a prescription medicine containing Ferumoxytol non-stoichiometric magnetite for intravenous use, marketed by AMAG Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). Excursions permitted to 15° to 30°C (59°…
Key facts
- Active ingredient (INN)
- Ferumoxytol non-stoichiometric magnetite
- Brand
- Feraheme
- Strength
- 510 mg/17 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 1 vial of 17 mL, 10 vials of 17 mL
- Marketing authorisation holder
- AMAG Pharmaceuticals
- Manufacturer
- AMAG Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). Excursions permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 13 July 2009
- Identifiers
- RxCUI 860605, 1191357DailyMed set ID 32b0e320-a739-11dc-a704-0002a5d5c51bNDC 59338-775Application NDA022180
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, single-use in 1 carton / 17 mL in 1 vial, single-use | 59338-775-01 | AMAG Pharmaceuticals | 13 July 2009 |
| 10 vial, single-use in 1 carton / 17 mL in 1 vial, single-use | 59338-775-10 | AMAG Pharmaceuticals | 13 July 2009 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Ferumoxytol non-stoichiometric magnetite 510 mg/17 mL injection.
Clinical summary
Ferumoxytol non-stoichiometric magnetite is a parenteral iron replacement indicated for the treatment of iron deficiency anemia (IDA) in adult patients, among other approved uses. It is available as injection for intravenous use. MedsAcross supplies Ferumoxytol non-stoichiometric magnetite for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Ferumoxytol non-stoichiometric magnetiteFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Feraheme prescribing information (AMAG Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Feraheme 510 mg/17 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.